» Articles » PMID: 22414893

The Importance of Early Brain Injury After Subarachnoid Hemorrhage

Overview
Journal Prog Neurobiol
Specialty Neurology
Date 2012 Mar 15
PMID 22414893
Citations 275
Authors
Affiliations
Soon will be listed here.
Abstract

Aneurysmal subarachnoid hemorrhage (aSAH) is a medical emergency that accounts for 5% of all stroke cases. Individuals affected are typically in the prime of their lives (mean age 50 years). Approximately 12% of patients die before receiving medical attention, 33% within 48 h and 50% within 30 days of aSAH. Of the survivors 50% suffer from permanent disability with an estimated lifetime cost more than double that of an ischemic stroke. Traditionally, spasm that develops in large cerebral arteries 3-7 days after aneurysm rupture is considered the most important determinant of brain injury and outcome after aSAH. However, recent studies show that prevention of delayed vasospasm does not improve outcome in aSAH patients. This finding has finally brought in focus the influence of early brain injury on outcome of aSAH. A substantial amount of evidence indicates that brain injury begins at the aneurysm rupture, evolves with time and plays an important role in patients' outcome. In this manuscript we review early brain injury after aSAH. Due to the early nature, most of the information on this injury comes from animals and few only from autopsy of patients who died within days after aSAH. Consequently, we began with a review of animal models of early brain injury, next we review the mechanisms of brain injury according to the sequence of their temporal appearance and finally we discuss the failure of clinical translation of therapies successful in animal models of aSAH.

Citing Articles

Nanoparticle-Based Therapies for Management of Subarachnoid Hemorrhage, Neurotrauma, and Stroke.

Hey G, Mehkri I, Mehkri Y, Maqbool H, Tahirkheli M, Woodford S Biomedicines. 2025; 13(1).

PMID: 39857600 PMC: 11760890. DOI: 10.3390/biomedicines13010016.


Research progress of early brain Injury in subarachnoid hemorrhage from 2004 to 2024: a bibliometric analysis.

Ye H, Wang X, Xie W, Fu W, Liang Y, Tan J Neurosurg Rev. 2025; 48(1):75.

PMID: 39847142 DOI: 10.1007/s10143-025-03233-6.


Overexpression of Heme Oxygenase 1 Enhances the Neuroprotective Effects of Exosomes in Subarachnoid Hemorrhage by Suppressing Oxidative Stress and Endoplasmic Reticulum Stress.

Gao Q, Su Z, Pang X, Chen J, Luo R, Li X Mol Neurobiol. 2024; .

PMID: 39710823 DOI: 10.1007/s12035-024-04651-1.


Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage.

Yang B, Blackburn S, Lorenzi P, Choi H, Gusdon A Neurotherapeutics. 2024; 22(1):e00504.

PMID: 39701893 PMC: 11840353. DOI: 10.1016/j.neurot.2024.e00504.


Pioglitazone Modulates Microglia M1/M2 Polarization Through PPAR-γ Pathway and Exerts Neuroprotective Effects in Experimental Subarachnoid Hemorrhage.

Ding Y, Wang Y, Qi M, Zhang X, Wu D Mol Neurobiol. 2024; .

PMID: 39668302 DOI: 10.1007/s12035-024-04664-w.


References
1.
Nosko M, Weir B, Lunt A, Grace M, Allen P, Mielke B . Effect of clot removal at 24 hours on chronic vasospasm after SAH in the primate model. J Neurosurg. 1987; 66(3):416-22. DOI: 10.3171/jns.1987.66.3.0416. View

2.
Le Roux P, Elliott J, Newell D, Grady M, Winn H . Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg. 1996; 85(1):39-49. DOI: 10.3171/jns.1996.85.1.0039. View

3.
Friedrich V, Flores R, Muller A, Sehba F . Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage. Brain Res. 2010; 1354:179-87. PMC: 2933941. DOI: 10.1016/j.brainres.2010.07.040. View

4.
Hubschmann O . The role of calcium in parenchymal cell injury in subarachnoid haemorrhage. Neurol Res. 1987; 9(4):265-9. DOI: 10.1080/01616412.1987.11739806. View

5.
Ram Z, Sahar A, Hadani M . Vasospasm due to massive subarachnoid haemorrhage--a rat model. Acta Neurochir (Wien). 1991; 110(3-4):181-4. DOI: 10.1007/BF01400688. View